Loading...
Mutations of CpG dinucleotides located in the triiodothyronine (T3)-binding domain of the thyroid hormone receptor (TR) beta gene that appears to be devoid of natural mutations may not be detected because they are unlikely to produce the clinical phenotype of resistance to thyroid hormone.
Thyroid hormone receptor (TR) beta gene mutations identified in patients with resistance to thyroid hormone (RTH) revealed two clusters ("hot" areas) of mutations (RTHmut) in the triiodothyronine (T3)-binding domain. Furthermore, 45% of RTHmuts and 90% of recurring mutations are located in...
Na minha lista:
| Udgivet i: | J Clin Invest |
|---|---|
| Main Authors: | , , |
| Format: | Artigo |
| Sprog: | Inglês |
| Udgivet: |
American Society for Clinical Investigation
1994
|
| Fag: | |
| Online adgang: | https://ncbi.nlm.nih.govhttps://pmc.ncbi.nlm.nih.gov/articles/PMC296137/ https://ncbi.nlm.nih.govhttps://pubmed.ncbi.nlm.nih.gov/8040316/ https://ncbi.nlm.nih.govhttps://doi.org/10.1172/JCI117376 |
| Tags: |
Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!
|